Skin Cancer section

Skin Cancer News & Features

Inherited Genetic Markers Predictive of Survival Prognosis for Patients with Melanoma

Prognosis for patients with cutaneous melanoma may be predicted by an inherited genetic marker providing a personalized tool to gauge a person's survival and determine if closer monitoring is needed in the years following surgery.

Prognosis Is Poor for Women With Pregnancy-Associated Melanoma

A recent study showed that women younger than 50 years who are pregnant or were recently pregnant at diagnosis of melanoma have a higher risk of death from the skin cancer.

Improved Progression-Free, Overall Survival Achieved With Dabrafenib, Trametinib Combo in Melanoma

Improved Progression-Free, Overall Survival Achieved With Dabrafenib, Trametinib Combo in Melanoma

Dabrafenib plus trametinib achieves good overall and progression-free survival in BRAF inhibitor-naïve patients with melanoma.

Using Mouse Avatars Aids Identification of Effective Targeted Therapies for Patients With Melanoma

Using xenograft mice as avatars of patients with melanoma, scientists demonstrated that a previously ineffective targeted drug may halt disease progression in certain patients.

Circulating Tumor DNA More Effective Than LDH at Detecting Metastatic Melanoma Progression, Recurrence

Metastatic melanoma disease activity may be monitored via circulating tumor DNA, which has higher sensitivity than lactate dehydrogenase for detecting disease progression.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs